Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications

TO Metz, NL Alderson, SR Thorpe… - Archives of biochemistry …, 2003 - Elsevier
Pyridoxamine (PM), originally described as a post-Amadori inhibitor of formation of
advanced glycation end-products (AGEs), also inhibits the formation of advanced …

Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice

R Tamarat, JS Silvestre, M Huijberts… - Proceedings of the …, 2003 - National Acad Sciences
We hypothesized that formation of advanced glycation end products (AGEs) associated with
diabetes reduces matrix degradation by metalloproteinases (MMPs) and contributes to the …

iNOS is a mediator of the heat stress-induced preconditioning against myocardial infarction in vivo in the rat

C Arnaud, D Godin-Ribuot, S Bottari… - Cardiovascular …, 2003 - academic.oup.com
Objective: The inducible isoform of nitric oxide synthase (iNOS) is known to be a trigger of
the heat stress (HS)-induced cardioprotection. Since iNOS also appears to mediate various …

Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2–dependent mechanism

Q Li, Y Guo, YT Xuan, CJ Lowenstein… - Circulation …, 2003 - Am Heart Assoc
Although the inducible isoform of NO synthase (iNOS) mediates late preconditioning (PC), it
is unknown whether iNOS gene transfer can replicate the cardioprotective effects of late PC …

Mechanism of cyclooxygenase-2 upregulation in late preconditioning

YT Xuan, Y Guo, Y Zhu, H Han, R Langenbach… - Journal of molecular and …, 2003 - Elsevier
Although the cardioprotection of late preconditioning (PC) is known to be mediated by both
inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2), the signaling mechanism …

1, 2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo

AC Tinker, HG Beaton, N Boughton-Smith… - Journal of medicinal …, 2003 - ACS Publications
The discovery of a novel class of nitric oxide synthase (NOS) inhibitors, 2-substituted 1, 2-
dihydro-4-quinazolinamines, and the related 4 '-aminospiro [piperidine-4, 2 '(1 'H) …

Comparison of iNOS inhibition by antisense and pharmacological inhibitors after spinal cord injury

DD Pearse, K Chatzipanteli, AE Marcillo… - … of Neuropathology & …, 2003 - academic.oup.com
Inducible nitric oxide synthase (iNOS) is a key mediator of inflammation during pathological
conditions. We examined, through the use of selective iNOS inhibitors, the role of iNOS in …

Interleukin-10 induction of nitric-oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells

M Cattaruzza, W Słodowski, M Stojakovic… - Journal of Biological …, 2003 - ASBMB
Interleukin-10 (IL-10) is a potent anti-inflammatory cytokine in Th1 cell-mediated chronic
inflammatory diseases such as, eg Crohn's disease. Moreover, IL-10 has been shown to …

Modulation of Virulence by Two Acidified Nitrite-Responsive Loci of Salmonella enterica Serovar Typhimurium

CC Kim, D Monack, S Falkow - Infection and immunity, 2003 - Am Soc Microbiol
Two acidified nitrite-inducible genes of Salmonella enterica serovar Typhimurium were
identified with a green fluorescent protein-based promoter-trap screen. The nitrite-inducible …

Blunted stress responses in delayed type hypersensitivity in mice lacking the neuronal isoform of nitric oxide synthase

SD Bilbo, AK Hotchkiss, S Chiavegatto… - Journal of …, 2003 - Elsevier
Nitric oxide (NO) is implicated in inflammation and hypothalamic–pituitary responses to
immune stimuli; however, the specific role of NO from neurons during stress-induced …